Axel Gaston Glasmacher
Chairman chez 4D PHARMA PLC
Profil
Dr. Axel Gaston Glasmacher, MD, is an Independent Director at Active Biotech AB, a Non-Executive Chairman at 4D Pharma Plc, a General Director at AG Life Science Consulting Gmbh & Co. Kg, a General Director at Glasmacher Verwaltungs GmbH and a Treasurer & Director at The Cancer Drug Development Forum.
He is on the Board of Directors at AvenCell Therapeutics, Inc., Active Biotech AB, Ryvu Therapeutics SA and The Cancer Drug Development Forum.
Dr. Glasmacher was previously employed as a Senior VP-Global Clinical Research & Development by Celgene Corp.
He received his undergraduate degree from the University of Bonn and a doctorate degree from the University of Bonn.
Postes actifs de Axel Gaston Glasmacher
| Sociétés | Poste | Début |
|---|---|---|
| 4D PHARMA PLC | Chairman | 17/04/2020 |
| RYVU THERAPEUTICS S.A. | Director/Board Member | 01/10/2019 |
| ACTIVE BIOTECH AB | Director/Board Member | 01/01/2020 |
| The Cancer Drug Development Forum | Director/Board Member | - |
| AG Life Science Consulting Gmbh & Co. Kg | Chief Executive Officer | - |
| Glasmacher Verwaltungs GmbH | Chief Executive Officer | - |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Board Member | 01/07/2021 |
Anciens postes connus de Axel Gaston Glasmacher
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Chief Tech/Sci/R&D Officer | 01/02/2018 |
Formation de Axel Gaston Glasmacher
| University of Bonn | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| Entreprise privées | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| The Cancer Drug Development Forum | |
| AG Life Science Consulting Gmbh & Co. Kg | |
| Glasmacher Verwaltungs GmbH | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
